FITC-Labeled Human Her2/ErbB2 Protein

<strong>FITC-Labeled Human Her2/ErbB2 Protein</strong>_x000D_ <strong>Catalog number:</strong> B2014834_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 10 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 96 kDa_x000D_ <strong>Supplied as:</strong> Lyophilized_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> ERBB2, CD340, HER-2, neu, HER2, MLN19, NEU, NGL, TKR1_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Kanomata N, Kurebayashi J, Moriya T. Phosphorylated HER3 and FITC-labeled trastuzumab immunohistochemistry in patients with HER2-positive breast cancer treated with adjuvant trastuzumab Med Mol Morphol. 2019 Jun;52(2):106-113._x000D_ 2: Rait AS, Pirollo KF, Ulick D, Cullen K, Chang EH. HER-2-targeted antisense oligonucleotide results in sensitization of head and neck cancer cells to chemotherapeutic agents Ann N Y Acad Sci. 2003 Dec;1002:78-89._x000D_ 3: Maiti KK, Dinish US, Fu CY, Lee JJ, Soh KS, Yun SW, Bhuvaneswari R, Olivo M, Chang YT. Development of biocompatible SERS nanotag with increased stability by chemisorption of reporter molecule for in vivo cancer detection Biosens Bioelectron. 2010 Oct 15;26(2):398-403._x000D_ 4: Guo XF, Zhu XF, Shang Y, Zhang SH, Zhen YS. A bispecific enediyne-energized fusion protein containing ligand-based and antibody-based oligopeptides against epidermal growth factor receptor and human epidermal growth factor receptor 2 shows potent antitumor activity Clin Cancer Res. 2010 Apr 1;16(7):2085-94._x000D_ 5: Tamada K, Geng D, Sakoda Y, Bansal N, Srivastava R, Li Z, Davila E. Redirecting gene-modified T cells toward various cancer types using tagged antibodies Clin Cancer Res. 2012 Dec 1;18(23):6436-45._x000D_ 6: Yang T, Zhang Y, Chen Y, Wang P, Zhao J, Yang A, Yan B. [Expression of modified humanized immunoapoptotic protein and its specific killing effect on HER2-positive tumor cells] Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2019 Dec;35(12):1109-1114._x000D_ 7: Westerlund K, Vorobyeva A, Mitran B, Orlova A, Tolmachev V, Karlström AE, Altai M. Site-specific conjugation of recognition tags to trastuzumab for peptide nucleic acid-mediated radionuclide HER2 pretargeting Biomaterials. 2019 May;203:73-85._x000D_ 8: Garousi J, Lindbo S, Honarvar H, Velletta J, Mitran B, Altai M, Orlova A, Tolmachev V, Hober S. Influence of the N-Terminal Composition on Targeting Properties of Radiometal-Labeled Anti-HER2 Scaffold Protein ADAPT6 Bioconjug Chem. 2016 Nov 16;27(11):2678-2688._x000D_ 9: Kornberger P, Skerra A. Sortase-catalyzed in vitro functionalization of a HER2-specific recombinant Fab for tumor targeting of the plant cytotoxin gelonin MAbs. 2014 Mar-Apr;6(2):354-66._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/36788069">10: Robbins CJ, Fernandez AI, Han G, Wong S, Harigopal M, Podoll M, Singh K, Ly A, Kuba MG, Wen H, Sanders MA, Brock J, Wei S, Fadare O, Hanley K, Jorns J, Snir OL, Yoon E, Rabe K, Soong TR, Reisenbichler ES, Rimm DL. Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry Mod Pathol. 2023 Jan;36(1):100032. </a>_x000D_ _x000D_ <strong>Products Related to FITC-Labeled Human Her2/ErbB2 Protein can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>